Coming Soon

Kalvista Pharmaceuticals Limited

Registration Number 07543947

Trading name: KalVista Pharmaceuticals

KalVista Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for diseases with high unmet medical need, particularly in the area of diabetic eye disease and other ophthalmic conditions.

Company Overview

Company Name
Kalvista Pharmaceuticals Limited
Registration Number
07543947
Founded
25 February 2011
Age
14 years
Industry Region
South West England
Registered Postcode
SP4 0BF

Online Profile

Special Flags

Public Funding Received

Public Funding for Kalvista Pharmaceuticals Limited

2015-06-01
Clinical development to PoC of a novel oral plasma kallikrein inhibitor for the treatment of diabetic macular edema (DME)
Collaborative R&D
2014-02-01
The development of a companion diagnostic to improve patient management and pharmacoeconomics in diabetic retinopathy
GRD Development of Prototype
2012-12-01
Pre-clinical development of novel oral plasma kallikrein inhibitors for the treatment of diabetic macular edema
Collaborative R&D

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.